Syngenta share repurchases: end-year report

Thu Jan 3, 2013 1:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130103:nPnPH36232


BASEL, Switzerland, Jan. 3, 2013 /PRNewswire/ -- Syngenta has completed the
share repurchases authorized by the Annual General Meeting on  April 22, 2008.
The authorization allowed for the repurchase of up to 10 percent of outstanding
shares.

In total, 1,487,200 shares were repurchased between  March 8, 2010  and end
December 2012 through a second trading line on the SIX Swiss Exchange. This
represents 1.5 percent of outstanding shares at the time of authorization and a
total amount of  $402 million.

In accordance with motions passed at the Annual General Meetings on  April 19,
2011  and  April 24, 2012  a total of 1,473,700 shares have been canceled. The
company plans to propose the cancellation of the remaining 13,500 shares at a
subsequent Annual General Meeting.

Syngenta is one of the world's leading companies with more than 26,000 employees
in over 90 countries dedicated to our purpose: Bringing plant potential to life.
Through world-class science, global reach and commitment to our customers we
help to increase crop productivity, protect the environment and improve health
and quality of life. For more information about us please go to 
www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by
terminology such as 'expect', 'would', 'will', 'potential', 'plans',
'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such
statements may be subject to risks and uncertainties that could cause the actual
results to differ materially from these statements. We refer you to Syngenta's
publicly available filings with the U.S. Securities and Exchange Commission for
information about these and other risks and uncertainties. Syngenta assumes no
obligation to update forward-looking statements to reflect actual results,
changed assumptions or other factors. This document does not constitute, or form
part of, any offer or invitation to sell or issue, or any solicitation of any
offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or
Syngenta ADSs, nor shall it form the basis of, or be relied on in connection
with, any contract therefor.

 Syngenta International AG  Media contacts:               Analyst/Investor contacts:        
                                                                                            
 Media Office               Paul Barrett                  Jennifer Gough                    
 CH-4002 Basel              Switzerland  +41 61 323 2323  Switzerland  +41 61 323 5059      
 Switzerland                                              USA              +1 202 737 6521  
 Tel:  +41 61 323 2323                                                                      
 Fax: +41 61 323 2424       Daniel Braxton                Lars Oestergaard                  
                            Switzerland  +41 61 323 2323  Switzerland  +41 61 323 6793      
 www.syngenta.com                                         USA              +1 202 737 6520  


SOURCE  Syngenta
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.